Remove Community support Remove Insurance Remove Pharmaceuticals
article thumbnail

Behind the Smiles: Mental Health in South Korea’s High-Pressure Society

Mad in America

For example, insurance data reveals that propofol usage in medical institutions rose 12% in a single year, with only 15% of it being used under national health insurance coverage. At the same time, the use of psychiatric medicationincluding controlled psychotropic substancesis also climbing. The implication?

article thumbnail

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

Mad in America

For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Was it related to medical insurance or government programs? Moore: The last couple of questions are related to the pharmaceutical industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antidepressant Withdrawal: A Clinician’s Middle View

Mad in America

Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. This notable gap has raised some suspicion that the necessary research has not merely been overlooked but deliberately avoided.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

Iatrogenesis is social when medicine as an institution and a bureaucracy creates ill-health by increasing stress; by subverting autonomy and community support; and by depoliticizing sources of illness. For Illich, the iatrogenesis of modern medicine is clinical when harm to individuals results specifically from medical treatment.